Accession Number: | 0000899243-21-011920 |
Date: | 2021-03-15 |
Issuer: | FATE THERAPEUTICS INC (FATE) |
Original Submission Date: |
VALAMEHR BAHRAM
C/O FATE THERAPEUTICS, INC.
3535 GENERAL ATOMICS COURT, SUITE 200
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-15 | M | 25,000 | d | $2.90 | 120,740 | direct | ||
COMMON STOCK | 2021-03-15 | S | 3,957 | d | $90.89 | 116,783 | direct | ||
COMMON STOCK | 2021-03-15 | S | 8,416 | d | $91.94 | 108,367 | direct | ||
COMMON STOCK | 2021-03-15 | S | 8,404 | d | $92.64 | 99,963 | direct | ||
COMMON STOCK | 2021-03-15 | S | 3,205 | d | $93.75 | 96,758 | direct | ||
COMMON STOCK | 2021-03-15 | S | 1,018 | d | $94.59 | 95,740 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.9 | 2021-03-15 | deemed execution date | M | 25,000 (d) | 2026-01-07 | common stock 25,000 | $2.90 | 16,156 | direct |
ID | footnote |
---|---|
f1 | this transaction was effected pursuant to a rule 10b5-1 sales plan adopted by the reporting person on june 9, 2020. |
f2 | represents the weighted average sale price of the shares sold from $90.30 to $91.29 per share. the reporting person will provide, upon request by the commission staff, the issuer or a security holder of he issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. |
f3 | represents the weighted average sale price of the shares sold from $91.30 to $92.29 per share. |
f4 | represents the weighted average sale price of the shares sold from $92.31 to $93.27 per share. |
f5 | represents the weighted average sale price of the shares sold from $93.31 to $94.29 per share. |
f6 | represents the weighted average sale price of the shares sold from $94.40 to $94.90 per share. |
f7 | this option is fully vested. |